Table 2 Relationship between laboratory parameters and clinic-pathological characteristics of MEOT patients

 ≤50

31 (48.4%)

99.69 ± 76.67

3.43 ± 2.45

192.2 ± 72.38

 > 50

33 (51.6%)

82.00 ± 66.87

4.28 ± 7.76

194.3 ± 127.18

 P-value

0.3636

0.5812

0.9402

 I-II

41 (64.1%)

74.53 ± 65.18

2.76 ± 1.54

170.5 ± 73.25

 III-IV

23 (35.9%)

119.2 ± 82.68

5.85 ± 9.50

233.9 ± 138.79

 P-value

0.0202

0.0442

0.0194

 G1

36 (56.25%)

78.28 ± 69.06

2.89 ± 2.1

187.8 ± 74.88

 G2-G3

28 (43.75%)

106.37 ± 79.43

5.13 ± 8.57

200.4 ± 135.94

 P-value

0.1356

0.1345

0.6399

 Serous

24 (37.5%)

83.61 ± 64.07

5.01 ± 9.22

208.05 ± 144.06

 Mucinous

8 (12.5%)

86.93 ± 70.38

4.52 ± 3.73

200.92 ± 66.65

 Endometrioid

14 (21.9%)

120.44 ± 104.28

3.41 ± 2.22

181.56 ± 61.67

 Clear cell

18 (28.1%)

78.24 ± 60.69

2.42 ± 1.06

179.38 ± 87.07

 P-value

0.403

0.551

0.807

 Negative

51 (79.7%)

72.88 ± 8.93

2.69 ± 0.20

175.6 ± 10.37

 Positive

13 (20.3%)

159.97 ± 18.11

8.50 ± 3.36

262.7 ± 47.05

 P-value

< 0.0001

0.0012

0.0067